Scientific Research News

CHELMSFORD, England--(BUSINESS WIRE)--Teledyne Space Imaging, a leading supplier of space-qualified imaging sensors, focal plane arrays and integrated camera systems, announced it supplied two CCD370 imaging sensors for the Soft X-ray Imager on the European Space Agency’s SMILE mission (Solar wind Magnetosphere Ionosphere Link Explorer). SMILE successfully launched at 04:52 BST from Europe’s Spaceport in French Guiana. SMILE is a scientific collaboration designed to advance understanding of spa...

CHICAGO, NEW YORK, & SAN DIEGO--(BUSINESS WIRE)--CG Life has appointed Coco Douaihy as Chief Creative Officer to lead the next evolution of agency's creative offering for biopharma innovators....

BLUE BELL, Pa.--(BUSINESS WIRE)--Ladder Bio, Inc., a structure-guided biotechnology company developing Spiroligomers™, a new class of chemical matter as medicines, today announced the appointments of Jay Fine, PhD, and John Prufeta to its Board of Directors. The two appointments add deep drug development experience and defense-sector expertise as Ladder Bio advances its proprietary Spiroligomer™ platform across immunology, oncology, and biosecurity applications. Dr. Fine currently serves as Pre...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Portal Innovations, in partnership with the New Brunswick Development Corporation (DEVCO) and HELIX, today announced that Johnson & Johnson has secured naming rights to the Johnson & Johnson Exchange at the New Jersey Innovation Hub (NJIH), Powered by Portal Innovations. The collaboration reinforces Johnson & Johnson’s longstanding leadership in advancing innovation, entrepreneurship, and the life sciences sector in New Jersey, one of the nation...

MEMPHIS, Tenn.--(BUSINESS WIRE)--ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital®, today released The St. Jude Hope Imperative, a national survey of 2,501 U.S. adults conducted by The Harris Poll exploring how Americans understand, experience and practice hope. “Hope is an important part of the journeys of St. Jude patients and their families, and we wanted to better understand how it shows up across Americans’ daily lives, not just in moments of cris...

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced the launch of Flatiron Telescope, a next-generation AI-powered platform designed to help life sciences teams and researchers find the right patients faster, assess study feasibility in real time, and generate oncology insights on demand. Built on Flatiron’s industry-leading real-world data and powered by its multi-agent adaptive analytics engine, Flatiron Telescope enables teams across clinical development, RWE, and commercial functions...

NEW YORK--(BUSINESS WIRE)--Opentrons Labworks, Inc., a laboratory robotics company enabling AI-driven autonomous science, today announced Opentrons® Compliance Ready Software (Opentrons CRS), a new offering for the Opentrons Flex® robotic platform. The first U.S. FDA Title 21 CFR Part 11-aligned software designed for an accessible benchtop liquid handling platform, Opentrons CRS brings authentication, signed audit trails, role-based access, and electronic record integrity to the Flex, giving re...

SAN FRANCISCO--(BUSINESS WIRE)--Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology...

BRONX, N.Y.--(BUSINESS WIRE)--Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, today announced the clinical completion of the Phase 1a clinical study of its lead compound, OLX-07010. “Oligomerix is pleased to announce the clinical completion of Phase 1a of its clinical program seeking to bring forward a new treatment for patients suffering from neurodegenerative diseases. Phase...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the publication of its 2025 Corporate Responsibility Report. The 2025 report details how the company is scaling its corporate responsibility efforts in tandem with its business growth. Reflected throughout the report is the global theme, “Accepting Challenges to Improve the Health of Humanity,” which remains central to Alnylam’s strategy and is embedded across...